vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and NERDWALLET, INC. (NRDS). Click either name above to swap in a different company.
NERDWALLET, INC. is the larger business by last-quarter revenue ($225.4M vs $168.4M, roughly 1.3× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 22.6%). Over the past eight quarters, NERDWALLET, INC.'s revenue compounded faster (18.0% CAGR vs 10.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
NerdWallet is an American personal finance company, founded in 2009 by Tim Chen and Jacob Gibson. It has a website and app that earns money by promoting financial products to its users.
ESPR vs NRDS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $225.4M |
| Net Profit | — | $14.0M |
| Gross Margin | — | 94.0% |
| Operating Margin | 50.6% | 8.6% |
| Net Margin | — | 6.2% |
| Revenue YoY | 143.7% | 22.6% |
| Net Profit YoY | — | -63.7% |
| EPS (diluted) | $0.32 | $0.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $225.4M | ||
| Q3 25 | $87.3M | $215.1M | ||
| Q2 25 | $82.4M | $186.9M | ||
| Q1 25 | $65.0M | $209.2M | ||
| Q4 24 | $69.1M | $183.8M | ||
| Q3 24 | $51.6M | $191.3M | ||
| Q2 24 | $73.8M | $150.6M | ||
| Q1 24 | $137.7M | $161.9M |
| Q4 25 | — | $14.0M | ||
| Q3 25 | $-31.3M | $26.3M | ||
| Q2 25 | $-12.7M | $8.2M | ||
| Q1 25 | $-40.5M | $200.0K | ||
| Q4 24 | — | $38.6M | ||
| Q3 24 | $-29.5M | $100.0K | ||
| Q2 24 | $-61.9M | $-9.4M | ||
| Q1 24 | $61.0M | $1.1M |
| Q4 25 | — | 94.0% | ||
| Q3 25 | — | 92.9% | ||
| Q2 25 | — | 91.1% | ||
| Q1 25 | — | 91.3% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 90.7% | ||
| Q2 24 | — | 90.1% | ||
| Q1 24 | — | 91.2% |
| Q4 25 | 50.6% | 8.6% | ||
| Q3 25 | -11.4% | 16.0% | ||
| Q2 25 | 8.6% | 5.7% | ||
| Q1 25 | -34.0% | 0.3% | ||
| Q4 24 | -6.4% | 4.7% | ||
| Q3 24 | -31.0% | 3.5% | ||
| Q2 24 | 3.5% | -6.4% | ||
| Q1 24 | 52.5% | 2.3% |
| Q4 25 | — | 6.2% | ||
| Q3 25 | -35.9% | 12.2% | ||
| Q2 25 | -15.4% | 4.4% | ||
| Q1 25 | -62.2% | 0.1% | ||
| Q4 24 | — | 21.0% | ||
| Q3 24 | -57.2% | 0.1% | ||
| Q2 24 | -83.9% | -6.2% | ||
| Q1 24 | 44.3% | 0.7% |
| Q4 25 | $0.32 | $0.19 | ||
| Q3 25 | $-0.16 | $0.34 | ||
| Q2 25 | $-0.06 | $0.11 | ||
| Q1 25 | $-0.21 | $0.00 | ||
| Q4 24 | $-0.14 | $0.49 | ||
| Q3 24 | $-0.15 | $0.00 | ||
| Q2 24 | $-0.33 | $-0.12 | ||
| Q1 24 | $0.34 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $98.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $374.5M |
| Total Assets | $465.9M | $461.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $98.3M | ||
| Q3 25 | $92.4M | $120.6M | ||
| Q2 25 | $86.1M | $105.3M | ||
| Q1 25 | $114.6M | $92.2M | ||
| Q4 24 | $144.8M | $66.3M | ||
| Q3 24 | $144.7M | $71.7M | ||
| Q2 24 | $189.3M | $113.8M | ||
| Q1 24 | $226.6M | $110.9M |
| Q4 25 | $-302.0M | $374.5M | ||
| Q3 25 | $-451.4M | $402.4M | ||
| Q2 25 | $-433.5M | $390.0M | ||
| Q1 25 | $-426.2M | $371.6M | ||
| Q4 24 | $-388.7M | $364.2M | ||
| Q3 24 | $-370.2M | $322.4M | ||
| Q2 24 | $-344.2M | $379.4M | ||
| Q1 24 | $-294.3M | $378.7M |
| Q4 25 | $465.9M | $461.1M | ||
| Q3 25 | $364.0M | $492.8M | ||
| Q2 25 | $347.1M | $476.0M | ||
| Q1 25 | $324.0M | $475.0M | ||
| Q4 24 | $343.8M | $437.6M | ||
| Q3 24 | $314.1M | $402.4M | ||
| Q2 24 | $352.3M | $446.2M | ||
| Q1 24 | $373.1M | $446.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $38.9M |
| Free Cash FlowOCF − Capex | — | $38.6M |
| FCF MarginFCF / Revenue | — | 17.1% |
| Capex IntensityCapex / Revenue | 0.0% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 2.78× |
| TTM Free Cash FlowTrailing 4 quarters | — | $130.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $38.9M | ||
| Q3 25 | $-4.3M | $48.5M | ||
| Q2 25 | $-31.4M | $17.5M | ||
| Q1 25 | $-22.6M | $26.7M | ||
| Q4 24 | $-35.0M | $9.9M | ||
| Q3 24 | $-35.3M | $29.0M | ||
| Q2 24 | $-7.2M | $10.2M | ||
| Q1 24 | $53.8M | $22.7M |
| Q4 25 | — | $38.6M | ||
| Q3 25 | — | $48.4M | ||
| Q2 25 | — | $16.8M | ||
| Q1 25 | — | $26.5M | ||
| Q4 24 | — | $9.7M | ||
| Q3 24 | $-35.5M | $28.9M | ||
| Q2 24 | $-7.3M | $9.9M | ||
| Q1 24 | $53.8M | — |
| Q4 25 | — | 17.1% | ||
| Q3 25 | — | 22.5% | ||
| Q2 25 | — | 9.0% | ||
| Q1 25 | — | 12.7% | ||
| Q4 24 | — | 5.3% | ||
| Q3 24 | -68.7% | 15.1% | ||
| Q2 24 | -9.9% | 6.6% | ||
| Q1 24 | 39.0% | — |
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.0% | 0.4% | ||
| Q1 25 | 0.0% | 0.1% | ||
| Q4 24 | 0.0% | 0.1% | ||
| Q3 24 | 0.3% | 0.1% | ||
| Q2 24 | 0.1% | 0.2% | ||
| Q1 24 | 0.1% | 0.0% |
| Q4 25 | — | 2.78× | ||
| Q3 25 | — | 1.84× | ||
| Q2 25 | — | 2.13× | ||
| Q1 25 | — | 133.50× | ||
| Q4 24 | — | 0.26× | ||
| Q3 24 | — | 290.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | 20.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
NRDS
| Insurance | $81.2M | 36% |
| Emerging Verticals | $52.9M | 23% |
| Loans | $42.3M | 19% |
| Credit Card | $26.5M | 12% |
| SMB Products | $22.5M | 10% |
